JESSICA GLASS: Open Payments
NPI 1316669716 · OXFORD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 19 payments from 11 companies in 2025. Trend: 2023 $175 · 2024 $382 · 2025 $358
Food & beverage: $313Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| Novo Nordisk Inc | 5 | $75 |
| Lilly USA, LLC | 1 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Dexcom, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: QULIPTA, Ozempic, Wegovy, UBRELVY, Dexcom G6 Transmitter, BREZTRI, JARDIANCE, Korlym.
Industry payments across AL — which companies pay providers there.
